| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 07/22/2009 | EP1940464B1 Hexosylceramides as adjuvants and their uses in pharmaceutical compositions |
| 07/22/2009 | EP1868452B1 Hydroxydeoxybenzoins and the use thereof to mask a bitter taste |
| 07/22/2009 | EP1858555A4 Fucoidan compositions and methods for dietary and nutritional supplements |
| 07/22/2009 | EP1694292B1 Therapeutic foam comprising a sclerosing solution and a low quanitiy of gaseous nitrogen |
| 07/22/2009 | EP1499290B1 Warming and nonirritating lubricant compositions |
| 07/22/2009 | EP1458413B1 Pharmaceutical compositions based on azetidine derivatives |
| 07/22/2009 | EP1392337B2 Pharmaceutical formulation consisting of a plant dry extract with a calcium coating |
| 07/22/2009 | EP1392241B1 System for osmotic delivery of pharmaceutically active agents |
| 07/22/2009 | EP1379224B1 Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis |
| 07/22/2009 | EP1343518B1 Stabilized interferon compositions |
| 07/22/2009 | EP1282447B1 Stable polymeric micelle-type drug composition and method for the preparation thereof |
| 07/22/2009 | EP1255563B1 Composition of antigen and glycolipid adjuvant sublingual administration |
| 07/22/2009 | EP1133517B1 INTRANUCLEAR TARGETED DELIVERY OF COMPOUNDS BY 70 kD HEAT SHOCK PROTEIN |
| 07/22/2009 | EP1109563A4 End modified thermal responsive hydrogels |
| 07/22/2009 | EP1027033B1 High efficiency encapsulation of nucleic acids in lipid vesicles |
| 07/22/2009 | EP0954326B2 A process for viral inactivation of lyophilized blood proteins |
| 07/22/2009 | CN101489592A Polymer conjugate of combretastatin |
| 07/22/2009 | CN101485887A 5-fluorouracil-sn2-phosphatidyl choline copolymer as well as preparation method and application thereof |
| 07/22/2009 | CN101485886A Blood platelet additive solution and preparation method thereof |
| 07/22/2009 | CN100516203C In vitro cell culturing method |
| 07/22/2009 | CN100516007C Process for preparing stereo arrested amine nitrogen oxygen free redical with hydrotalcite analog as catalyst |
| 07/22/2009 | CN100515499C Nucleoside phosphorus acylated coupling chitosan derivant and method of producing the same and application of the same |
| 07/22/2009 | CN100515498C Method for preparing composite nano-polymers to inhibit tumor multidrug resistance |
| 07/22/2009 | CN100515497C Liposomal delivery of vitamin E based compounds |
| 07/22/2009 | CN100515495C Lyophilized preparation containing antibodies to the EGF receptor |
| 07/22/2009 | CN100515492C Mixtures of calcitonin drug-oligomer conjugates comprising polyalkylene glycol, purpose thereof and method of making same |
| 07/22/2009 | CN100515422C Composition containing benzamidine derivative and method for stabilizing benzamidine derivative |
| 07/22/2009 | CN100515416C A herbal molecule as potential anti-leukemic drug |
| 07/22/2009 | CN100515392C Dry powder composition for improvement of effective position medical deposit |
| 07/22/2009 | CN100515384C Composition containing perfluoropolyether phosphates |
| 07/21/2009 | US7563876 For binding and blocking human mannose receptors; fibronectins; immunoglobulins; cd antigens; cytolysis; cytotoxic lymphocytes; for treatment of automimmune diseases |
| 07/21/2009 | US7563824 Clathrate complexes formed by hyaluronic acid derivatives and use thereof as pharmaceuticals |
| 07/21/2009 | US7563773 praziquantel and ivermectin dissolved in glycerol formal, with thickener for improved bioavailability |
| 07/21/2009 | US7563765 Histidine-rich glycoprotein |
| 07/21/2009 | US7563763 FSH and FSH variant formulations, products and methods |
| 07/21/2009 | US7563761 PNA conjugate for the treatment of diseases associated with HIV |
| 07/21/2009 | US7563463 Cosmetic slimming composition containing an extract of biomass of the alga Neochloris oleoabundans |
| 07/21/2009 | US7563459 Administering a glycoconjugated asialoorosomucoid and the stem cell to the mammal for drug delivering to a target tissue; regenerating heart tissue; tissue-targeted therapy, gene therapy |
| 07/21/2009 | US7563457 Nanoparticle assembled hollow spheres |
| 07/21/2009 | US7563446 Administering a phosphatidylserine/polypeptide conjugate with polypeptide being bovine serum albumin, keyhole limpet hemocyanin, bovine gamma-globulin, diphtheria toxin, or beta 2-glycoprotein |
| 07/21/2009 | US7562769 Formulation and presentation of medicaments |
| 07/21/2009 | CA2479749C Test system for evaluating the compatibility of biologically active substances with copolymers |
| 07/21/2009 | CA2474698C Polymer-based compositions for sustained release |
| 07/21/2009 | CA2409845C Active substance combination containing a compound with an opioid effect and at least one further compound of formula i |
| 07/21/2009 | CA2408848C Rapidly disintegrating solid oral dosage form |
| 07/21/2009 | CA2406650C Cationic diagnostic, imaging and therapeutic agents associated with activated vascular sites |
| 07/21/2009 | CA2382098C Sustained-release, oral pharmaceutical forms of administration |
| 07/21/2009 | CA2380481C Process for preparing a charcoal-gm1 complex |
| 07/21/2009 | CA2328528C Therapeutics using a bispecific anti-hla class ii invariant chain x anti-pathogen antibody |
| 07/21/2009 | CA2261690C Antiprotozoal composition |
| 07/16/2009 | WO2009089181A1 Insulin formulations for insulin release as a function of tissue glucose levels |
| 07/16/2009 | WO2009089053A1 Oligomer-guanidine class conjugates |
| 07/16/2009 | WO2009088826A1 Liquid antiseptic compositions containing iodine and a sugar and/or sugar alcohol |
| 07/16/2009 | WO2009088414A2 Oral pharmaceutical dosage forms |
| 07/16/2009 | WO2009088042A1 Atomizing agent for prevention of infection with influenza virus |
| 07/16/2009 | WO2009087987A1 Composition for improving nutritional status, reducing frequency of fever and/or increasing immunocompetence of elderly |
| 07/16/2009 | WO2009087665A2 Gastroretentive drug delivery system |
| 07/16/2009 | WO2009087663A2 Oral controlled release coated tablet |
| 07/16/2009 | WO2009087660A1 Stable oxaliplatin composition for parenteral administration |
| 07/16/2009 | WO2009087647A1 A stabilized iodine-water concentrate formulation useful for protection against iodine deficiency disorders |
| 07/16/2009 | WO2009087632A2 Emulsified wax compositions and uses thereof |
| 07/16/2009 | WO2009087485A2 Topical compositions for delivery of proteins and peptides |
| 07/16/2009 | WO2009086942A1 Coated pharmaceutical or nutraceutical preparation with accelerated controlled active substance release |
| 07/16/2009 | WO2009086941A1 Coated pharmaceutical or nutraceutical preparation with enhanced pulsed active substance release |
| 07/16/2009 | WO2009086940A1 Coated pharmaceutical or nutraceutical preparation with enhanced active substance release in the colon |
| 07/16/2009 | WO2009086695A1 Use of extractive of bcg polysaccharide and nucleic acid for preparing medicine for treating allergic dermatosis, and its injection and preparation method |
| 07/16/2009 | WO2009086694A1 Use of extractive of bcg polysaccharide and nucleic acid for preparing medicine for treating viral skin diseases, and its injection and preparation method |
| 07/16/2009 | WO2009086656A1 Y-type polyethylene glycol modified g-csf and preparation method and use thereof |
| 07/16/2009 | WO2009065946A3 Pharmaceutical kit consisting of an oil-in-water emulsion and a solid composition |
| 07/16/2009 | WO2009064964A3 Switchable nano-vehicle delivery systems, and methods for making and using them |
| 07/16/2009 | WO2009059984A3 Reversible hydrophobization of antitumor drugs for enhanced first-pass drug uptake |
| 07/16/2009 | WO2009048958A3 Methods and compositions involving chitosan nanoparticles |
| 07/16/2009 | WO2008153744A3 Polymeric carriers for immunohistochemistry and in situ hybridization |
| 07/16/2009 | WO2008153611A3 Sustained delivery formulations of risperidone compounds |
| 07/16/2009 | WO2008146016A3 Cyclodextrins for administering fatty acids in tablets |
| 07/16/2009 | WO2008079464A8 Stable powder formulations of alum-adsorbed vaccines |
| 07/16/2009 | WO2008066902A3 Method for preparing a polymer conjugate |
| 07/16/2009 | WO2008012542A8 Polysaccharide derivatives of erythropoietin |
| 07/16/2009 | WO2007113531A8 Topical drug delivery |
| 07/16/2009 | WO2007098611A8 Compositions for treatment of cancer |
| 07/16/2009 | WO2004055164A3 System and method for stabilizing antibodies with histidine |
| 07/16/2009 | WO2003038054A3 Structure-based design and synthesis of fgf inhibitors and fgf modulator compounds |
| 07/16/2009 | WO2002087497A3 Therapeutic agent/ligand conjugate compositions, their methods of synthesis and use |
| 07/16/2009 | US20090182125 Stability, reduced toxicity; covalently linked imidazole functionality |
| 07/16/2009 | US20090182063 Rgd-enriched gelatine-like proteins with enhanced cell binding |
| 07/16/2009 | US20090182062 Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom |
| 07/16/2009 | US20090182061 Method for Making comb polymers by drying then functionalization of the Meth(Acrylic)Polymer Backbone,Resulting Polymers and uses thereof |
| 07/16/2009 | US20090182060 W/o/w type emulsified composition |
| 07/16/2009 | US20090182047 Utilization of dialkylfumarates |
| 07/16/2009 | US20090181954 Patches, formulations, and associated methods for transdermal delivery of alprazolam and other drugs |
| 07/16/2009 | US20090181930 Kinase inhibitory phosphonate analogs |
| 07/16/2009 | US20090181927 Bonding tissues and cross-linking proteins with naphthalimide compounds |
| 07/16/2009 | US20090181898 Abuse-resistant amphetamine prodrugs |
| 07/16/2009 | US20090181895 Stabilised Compositions of Factor VII Polypeptides |
| 07/16/2009 | US20090181894 Chimeric toxins for targeted therapy |
| 07/16/2009 | US20090181437 Method for producing a conjugated linoleic acid glyceride |
| 07/16/2009 | US20090181090 Protein-Based Carrier System for Overcoming Resistance in Tumour Cells |
| 07/16/2009 | US20090181085 Use of certain dialkyl fumarates for the preparation of pharmaceutical preparations for use in transplantation medicine or for the therapy of autoimmune diseases and said compositions in the form of micro-tablets or pellets; dimethyl fumarate |
| 07/16/2009 | US20090181069 Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom |
| 07/16/2009 | US20090181063 Implantable medical device comprising a pro-healing poly(ester-amide) |